SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jonathan Skupsky, Ke-Qin Hu, Current hepatitis B treatment guidelines and future research directions, Frontiers of Medicine, 2014, 8, 2, 145

    CrossRef

  2. 2
    Anil Seetharam, Robert Perrillo, Robert Gish, Immunosuppression in Patients with Chronic Hepatitis B, Current Hepatology Reports, 2014, 13, 3, 235

    CrossRef

  3. You have free access to this content3
    JSH Guidelines for the Management of Hepatitis B Virus Infection, Hepatology Research, 2014, 44,
  4. 4
    Mei Lan Huang, Xi Tao Xu, Jun Shen, Yu Qi Qiao, Zhang Han Dai, Zhi Hua Ran, Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: A retrospective study, Journal of Crohn's and Colitis, 2014, 8, 4, 282

    CrossRef

  5. 5
    Mar Riveiro-Barciela, María Buti, Virus de la hepatitis B en el embarazo y el paciente inmunosuprimido, Gastroenterología y Hepatología, 2014,

    CrossRef

  6. 6
    Chunchen Wu, Hui Shi, Mengji Lu, Yang Xu, Xinwen Chen, A case of hepatitis B reactivation in an anti-HBs positive, anti-HBc positive non-Hodgkin’s lymphoma patient, Virologica Sinica, 2013, 28, 1, 49

    CrossRef

  7. 7
    Konrad Namberger, Lukas Weiss, Barbara Krause, Thomas Melchardt, Richard Greil, A case of long-term remission with ofatumumab maintenance therapy in multiply relapsed and rituximab-refractory chronic lymphocytic leukaemia with deletion 17p, European Journal of Haematology, 2013, 90, 4
  8. 8
    Jessica P. Hwang, Anna S.-F. Lok, Management of patients with hepatitis B who require immunosuppressive therapy, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 4, 209

    CrossRef

  9. 9
    Jessica P Hwang, Michael J Fisch, Anna S-F Lok, Hong Zhang, John M Vierling, Maria E Suarez-Almazor, Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center, BMC Cancer, 2013, 13, 1, 534

    CrossRef

  10. 10
    Aiko Kida, George B. McDonald, Gastrointestinal, Hepatobiliary, Pancreatic, and Iron-Related Diseases in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation, Seminars in Hematology, 2012, 49, 1, 43

    CrossRef

  11. 11
    Jessica P. Hwang, John M. Vierling, Andrew D. Zelenetz, Susan C. Lackey, Rohit Loomba, Hepatitis B virus management to prevent reactivation after chemotherapy: a review, Supportive Care in Cancer, 2012, 20, 11, 2999

    CrossRef

  12. 12
    L. Milazzo, M. Corbellino, A. Foschi, V. Micheli, A. Dodero, A. Mazzocchi, V. Montefusco, G. Zehender, S. Antinori, Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy, Transplant Infectious Disease, 2012, 14, 1
  13. 13
    Seok Jin Kim, Joon Ho Moon, Hawk Kim, Jin Seok Kim, Yu Yan Hwang, Tanin Intragumtornchai, Surapol Issaragrisil, Jae Yong Kwak, Je Jung Lee, Jong Ho Won, Arry Harryanto Reksodiputro, Soon Thye Lim, Ann-Lii Cheng, Won Seog Kim, Yok Lam Kwong, Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group, Leukemia & Lymphoma, 2012, 53, 8, 1515

    CrossRef

  14. 14
    Seyed Moayed Alavian, Seyed Mohammad Miri, F. Blaine Hollinger, Seyed Mohammad Jazayeri, Occult Hepatitis B (OBH) in Clinical Settings, Hepatitis Monthly, 2012, 12, 8

    CrossRef

  15. 15
    Seyed Moayed Alavian, Seyed Mohammad Miri, F. Blaine Hollinger, Seyed Mohammad Jazayeri, Occult Hepatitis B (OBH) in Clinical Settings, Hepatitis Monthly, 2012, 12, 8

    CrossRef

  16. 16
    Harrys A. Torres, Marta Davila, Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer, Nature Reviews Clinical Oncology, 2012, 9, 3, 156

    CrossRef

  17. 17
    Jonathan G. Stine, Michael Bass, Dalia Ibrahim, Omar S. Khokhar, James H. Lewis, Dermatologists’ Awareness of and Screening Practices for Hepatitis B Virus Infection Before Initiating Tumor Necrosis Factor-α Inhibitor Therapy, Southern Medical Journal, 2011, 104, 12, 781

    CrossRef

  18. 18
    Carlo Marinone, Monica Mestriner, HBV disease: HBsAg carrier and occult B infection reactivation in haematological setting, Digestive and Liver Disease, 2011, 43, S49

    CrossRef

  19. 19
    Samuel E Moses, ZiYi Lim, Mark A Zuckerman, Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients, Expert Review of Anti-infective Therapy, 2011, 9, 10, 891

    CrossRef

  20. 20
    J. P. Gisbert, M. Chaparro, M. Esteve, Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2011, 33, 6
  21. 21
    Kavitha Gopal, Albert D. Min, Chemoprevention of Patients with Hepatitis B Receiving Chemotherapy or Bone Marrow Transplant, Current Hepatitis Reports, 2010, 9, 3, 178

    CrossRef

  22. 22
    D. Francisci, F. Falcinelli, E. Schiaroli, M. Capponi, B. Belfiori, L. Flenghi, F. Baldelli, Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy, Infection, 2010, 38, 1, 58

    CrossRef

  23. 23
    Jonathan G. Stine, Omar S. Khokhar, John Charalambopoulos, Victoria K. Shanmugam, James H. Lewis, Rheumatologists' awareness of and screening practices for Hepatitis B virus infection prior to initiating immunomodulatory therapy, Arthritis Care & Research, 2010, 62, 5
  24. 24
    Paolo Ricchi, Patrizia Cinque, Alfonso Lanza Galeota, Tiziana Di Matola, Massimiliano Ammirabile, Luciano Prossomariti, Hepatitis B virus reactivation during combined therapy with deferiprone and desferioxamine in a hepatitis B surface antigen thalassemic carrier, International Journal of Hematology, 2009, 89, 2, 135

    CrossRef

  25. 25
    Winnie Yeo, Hepatitis B virus reactivation in association with antineoplastic therapy, Current Hepatitis Reports, 2009, 8, 3, 127

    CrossRef

  26. 26
    R. Liang, How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation, Blood, 2009, 113, 14, 3147

    CrossRef

  27. 27
    Davide Rossi, Lisa Sala, Rosalba Minisini, Carlo Fabris, Edmondo Falleti, Michaela Cerri, Michela Emma Burlone, Pierluigi Toniutto, Gianluca Gaidano, Mario Pirisi, Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia, Leukemia & Lymphoma, 2009, 50, 4, 604

    CrossRef

  28. 28
    Carme Loras, Cristina Saro, Ferràn Gonzalez-Huix, Miguel Mínguez, Olga Merino, Javier P Gisbert, Jesús Barrio, Antonio Bernal, Ana Gutiérrez, Marta Piqueras, Xavier Calvet, Montserrat Andreu, Agueda Abad, Daniel Ginard, Luis Bujanda, Julián Panés, Miquel Torres, Fernando Fernández-Bañares, Josep M Viver, Maria Esteve, Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study, The American Journal of Gastroenterology, 2009, 104, 1, 57

    CrossRef

  29. 29
    Tara N. Palmore, Neeral L. Shah, Rohit Loomba, Brian B. Borg, Uri Lopatin, Jordan J. Feld, Farooq Khokhar, Glen Lutchman, David E. Kleiner, Neal S. Young, Richard Childs, A. John Barrett, T. Jake Liang, Jay H. Hoofnagle, Theo Heller, Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression, Clinical Gastroenterology and Hepatology, 2009, 7, 10, 1130

    CrossRef

  30. 30
    Sagnelli Evangelista, Imparato Michele, Coppola Nicola, Pisapia Raffaella, Sagnelli Caterina, Messina Vincenzo, Piai Guido, Stanzione Maria, Bruno Marika, Moggio Giovanni, Caprio Nunzio, Pasquale Giuseppe, Del Vecchio Blanco Camillo, Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: A multicenter study, Journal of Medical Virology, 2008, 80, 9
  31. 31
    George K. K. Lau, Hepatitis B reactivation after chemotherapy: two decades of clinical research, Hepatology International, 2008, 2, 2, 152

    CrossRef

  32. 32
    Masami Miyagawa, Masahito Minami, Kota Fujii, Rei Sendo, Kojiro Mori, Daisuke Shimizu, Tomoaki Nakajima, Kohichiroh Yasui, Yoshito Itoh, Masafumi Taniwaki, Takeshi Okanoue, Toshikazu Yoshikawa, Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab, Journal of Medical Virology, 2008, 80, 12
  33. 33
    Giovanni Raimondo, Giuseppe Navarra, Stefania Mondello, Lucy Costantino, Guido Colloredo, Eugenio Cucinotta, Gaetano Di Vita, Claudio Scisca, Giovanni Squadrito, Teresa Pollicino, Occult hepatitis B virus in liver tissue of individuals without hepatic disease, Journal of Hepatology, 2008, 48, 5, 743

    CrossRef

  34. 34
    Ali Amouri, Lassaad Chtourou, Leila Mnif, Nabi Tahri, Prise en charge de la réactivation virale B au cours d’un traitement chimiothérapique ou immunosuppresseur, La Presse Médicale, 2008, 37, 11, 1591

    CrossRef

  35. 35
    Ruth Barrena, María Delgado, Pilar López, Cristina Garmendia, Reactivación del VHB y hepatitis aguda fulminante en un paciente con HBsAg negativo y anti-HBs y anti-HBc positivos tras recibir tratamiento con quimioterapia, Medicina Clínica, 2008, 131, 15, 598

    CrossRef

  36. 36
    Chee-Kin Hui, Winnie W. Cheung, Kar-Wai Leung, Vincent C. C. Cheng, Bone S. F. Tang, Iris W. S. Li, John M. Luk, Nikki P. Lee, Yok-Lam Kwong, Wing-Yan Au, Kwok-Yung Yuen, George K. Lau, Raymond Liang, Retracted: Outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen, Hepatology, 2008, 48, 2
    Direct Link:
  37. 37
    G. Carosi, M. Rizzetto, Treatment of chronic hepatitis B: Recommendations from an Italian workshop, Digestive and Liver Disease, 2008, 40, 8, 603

    CrossRef

  38. 38
    F.P. Silveira, S. Husain, E.J. Kwak, P.K. Linden, A. Marcos, R. Shapiro, P. Fontes, J.W. Marsh, M. De Vera, K. Tom, N. Thai, H.P. Tan, A. Basu, K. Soltys, D.L. Paterson, Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab, Transplant Infectious Disease, 2007, 9, 1
  39. 39
    Giovanni Raimondo, Teresa Pollicino, Irene Cacciola, Giovanni Squadrito, Occult hepatitis B virus infection, Journal of Hepatology, 2007, 46, 1, 160

    CrossRef

  40. 40
    Sabine Awerkiew, Martin Däumer, Marcel Reiser, Ulrike C. Wend, Herbert Pfister, Rolf Kaiser, Wulf R. Willems, Wolfram H. Gerlich, Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient, Journal of Clinical Virology, 2007, 38, 1, 83

    CrossRef

  41. 41
    Gadi Lalazar, Deborah Rund, Daniel Shouval, Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies, British Journal of Haematology, 2007, 136, 5
  42. 42
    Jean Klastersky, Adverse effects of the humanized antibodies used as cancer therapeutics, Current Opinion in Oncology, 2006, 18, 4, 316

    CrossRef

  43. 43
    Winnie Yeo, Philip J. Johnson, Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy, Hepatology, 2006, 43, 2
  44. 44
    S.E. Moses, Z.Y. Lim, M. Sudhanva, S. Devereux, A.Y.L. Ho, A. Pagliuca, M. Zuckerman, G.J. Mufti, Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab, Journal of Medical Virology, 2006, 78, 12
  45. 45
    G. Perceau, N. Diris, O. Estines, C. Derancourt, S. Lévy, P. Bernard, Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma, British Journal of Dermatology, 2006, 155, 5
  46. 46
    Karin A. Thursky, Leon J. Worth, John F. Seymour, H. Miles Prince, Monica A. Slavin, Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab, British Journal of Haematology, 2006, 132, 1
  47. 47
    Errata, European Journal of Haematology, 2005, 75, 2
  48. 48
    Janice MY Brown, Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective, Current Opinion in Infectious Diseases, 2005, 18, 4, 352

    CrossRef